APEX Biologix Announces Appointment of Jeff Cambra to Board of Directors

CLEARWATER, Fla., May 1, 2026 - APEX Biologix, a leading regenerative medicine device company focused on advancing autologous biologic systems, announced the appointment of Jeff Cambra to its Board of Directors.

Cambra brings extensive experience across the medical device and therapeutics industry, with leadership roles spanning general management, sales, marketing, and product development. His background includes interventional pain, spine procedures, biologics, and medical technologies, along with experience supporting commercialization strategy, portfolio management, and strategic transactions.

“APEX Biologix is a leader in autologous biologics, grounded in a disciplined focus on clinically relevant, evidence-informed solutions. As regenerative medicine continues to evolve, our focus is on advancing how autologous biologics are applied in clinical practice. Jeff’s experience scaling MedTech organizations and guiding strategic growth will strengthen our ability to execute,” said Jim Rogers, Chief Executive Officer of APEX Biologix.

“APEX is operating at a pivotal point in the evolution of autologous biologics,” said Cambra. “The organization is well positioned to advance biologic therapies within regenerative medicine, and I look forward to contributing to its continued growth.”

His appointment reflects APEX Biologix’s continued investment in experienced leadership as the company advances its role in regenerative medicine and supports clinicians through clinically grounded, evidence-informed solutions.

About APEX Biologix

APEX Biologix is a regenerative medicine company specializing in the development and commercialization of autologous biologic systems for use at the point of care. An industry leader, APEX Biologix is dedicated to advancing the science, research, and responsible adoption of regenerative medicine by equipping physicians with high-quality products designed to support patient care. The company supports a range of biologic therapies through clinically advanced solutions, including platelet-rich plasma (PRP), bone marrow concentrate (BMC), and protein concentrate (PC). Learn more at apexbiologix.com or on LinkedIn at linkedin.com/company/apex-biologix.